Evidence-Based Diabetes Management > December 2017

Evidence-Based Diabetes Management - December 2017

January 08, 2018 – AJMC Staff
January 03, 2018 – AJMC Staff
December 19, 2017 – Mary Caffrey
An interview with one of the authors of a large observational study that has seen findings consistent with recent cardiovascular outcomes trials in SGLT2 inhibitors.
December 18, 2017 – Andrew Smith
Evidence is more robust on kidney function but not sufficient to make drug decisions, one expert said. A whole separate trial, called CREDENCE, is examining renal function in patients taking canagliflozin.
December 14, 2017 – Thomas R. Graf, MD
A chief medical officer for a major payer outlines the challenges making sure that certain high-cost therapies are directed to the patients who need them.
December 13, 2017 – Robert A. Gabbay, MD, PhD, FACP
From the Editor in Chief
December 13, 2017 – Mary Caffrey
The payment reform movement has changed the thinking about what can be done for patients with diabetes and heart failure, for the good of patients.
December 12, 2017 – Jeffrey Carr, MD, FACC, FSCAI
CMS can take steps to raise awareness, including a specific quality measure, to ensure that testing occurs prior to nontraumatic amputation. 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!